The risk of type 2 diabetes is increased in children and adults who exhibited fetal growth restriction. Placental insufficiency and intrauterine growth restriction (IUGR) are common obstetrical complications associated with fetal hypoglycemia and hypoxia that reduce the b-cell mass and insulin secretion. In the present study, we have defined the underlying mechanisms of reduced growth and proliferation, impaired metabolism, and defective insulin secretion previously established as complications in islets from IUGR fetuses. In an IUGR sheep model that recapitulates human IUGR, high-throughput RNA sequencing showed the transcriptome of islets isolated from IUGR and control sheep fetuses and identified the transcripts that underlie b-cell dysfunction. Functional analysis expanded mechanisms involved in reduced proliferation and dysregulated metabolism that include specific cell cycle regulators and growth factors and mitochondrial, antioxidant, and exocytotic genes. These data also identified immune responses, wnt signaling, adaptive stress responses, and the proteasome as mechanisms of b-cell dysfunction. The reduction of immunerelated gene expression did not reflect a change in macrophage density within IUGR islets. The present study reports the islet transcriptome in fetal sheep and established processes that limit insulin secretion and b-cell growth in fetuses with IUGR, which could explain the susceptibility to premature islet failure in adulthood. Islet dysfunction formed by intrauterine growth restriction increases the risk for diabetes. (Endocrinology 158: 743-755, 2017) 
I
ncreasing evidence has indicated important metabolic rearrangements in infants born with intrauterine growth restriction (IUGR), which result in a greater incidence of metabolic disease such as type 2 diabetes in adulthood. IUGR is a pathology commonly associated with placental insufficiency (1) . Fetal adaptations to nutrient and oxygen restriction alter organ development, most notably resulting in asymmetric growth. Fetal b-cells respond to nutrient availability by secreting insulin; however, the b-cell mass and function are reduced in IUGR fetuses (2, 3) . Additionally, small for gestational age children have mild disturbances of glucose tolerance that are associated with a lower insulinogenic index, illustrating persistent b-cell-specific defects (4).
Although human studies have identified the specific consequences of IUGR, the mechanistic explanations are limited for the development of b-cell dysfunction in utero. A model of placental insufficiency-induced IUGR in sheep recapitulates all reported features of human IUGR, including b-cell dysfunction (5) . The IUGR sheep fetuses are chronically hypoglycemic and hypoxemic and asymmetrically growth restricted at term (6) . Importantly, this model of IUGR captures the endocrine pancreas defects described in humans with severe IUGR (7) . Previous reports of IUGR sheep fetuses have identified limitations in insulin secretion responsiveness to secretagogues (8, 9) . These reductions were associated with decreases in b-cell mass, which was linked to slower rates of b-cell proliferation (8, 10) . Furthermore, islets isolated from near-term IUGR fetuses have defects in glucose oxidative metabolism, and b-cells, the predominant cellular component of fetal sheep islets, have less intracellular insulin content (11) . Together, this body of evidence identifies multiple defects in b-cells from IUGR fetuses that include proliferation, insulin synthesis, and oxidative metabolism.
The objective of the present study was to describe the underlying mechanisms of reduced growth and proliferation, impaired metabolism, and defective insulin secretion previously established in islets, specifically b-cells, from IUGR fetuses. We performed highthroughput RNA sequencing (RNAseq) to identify the molecular components that define the observed dysfunction in islets of IUGR fetuses. An underlying assumption for transcriptome analysis is that changes in transcript abundance will result in similar changes in protein abundance and biological activity; however, we recognize that this is not true for all genes. The present study has illustrated comprehensive RNAseq of islets from a relevant sheep model of fetal metabolic programming. Furthermore, whole transcriptome sequencing technologies are highly sensitive and independent of a priori knowledge, thus providing the opportunity to identify pathways and candidate genes previously undefined in islets from IUGR fetuses. Processes that are significantly enriched in the IUGR islet transcriptome indicate downregulation of immune signaling, suppressed Wnt signaling, adaptive stress responses, and proteolysis.
Materials and Methods

Animal care and use
Columbia-Rambouillet crossbred ewes carrying singleton pregnancies were managed in compliance with the institutional animal care and use committee. IUGR fetuses (n = 4) were generated by exposing pregnant ewes to elevated ambient temperatures (40°C for 12 hours and 35°C for 12 hours) from 37 6 3 days of gestational age until 120 6 3 days of gestational age, as previously described (11) . Control fetuses (n = 4) were age matched, and the ewes were pair fed to the average intake of ewes with IUGR fetuses. Males and females were included in all groups, and the sex effect was not evaluated; however, sex was not a factor in previous islet studies (9, 12) . The sheep were euthanized at 90% of gestation. The fetus was weighed, and the pancreatic islets were isolated, as described previously (11) . Intact islets from control fetuses (control islets) and islets from IUGR fetuses (IUGR islets) were compared.
RNAseq and analysis
The islets were handpicked and frozen for RNA extraction using Microprep RNeasy (QIAGEN, Hilden, Germany) (13) . RNA samples were submitted to the University of Arizona Genetics Core for high throughput sequencing. Messenger RNA was selected and double-stranded complementary DNA (cDNA) libraries with ligated sequencing adapters were constructed using the Illumina TruSeq RNA Sample Prep Kit (Illumina Inc., San Diego, CA), according to manufacturer's instructions. Cluster generation was conducted with the Illumina TruSEquation 100bp PE (paired end) cluster kit before running on the Illumina HiSeq2500 (four subjects/lane; two control and two IUGR). Adapter sequences were trimmed with Trimmomatic, and reads were assessed for quality with FastQC (Babraham Bioinformatics, Babraham Institute, Cambridge, UK).
Transcriptome assembly and differential gene expression analysis were conducted using the TopHat and Cufflinks programs (14, 15) . The analysis of these data followed the standard protocol published for the TopHat and Cufflinks programs (16) . Paired-end reads were aligned to the reference ovine (Ovis_aries.Oar_v3.1.74.toplevel.fa, Ensembl release 74) and bovine (bos taurus, UMD 3.1, Illumina iGenomes) genomes using Bowtie2, version 2.1.0 and TopHat, version 2.0.1. The read alignment parameters anchor length (215), anchor mismatch (21), intron length (250,000), mismatch (23) , and read gap length (24) were determined by titration to improve the overall read mapping rate and concordant pair mapping without inflating multiple alignments or discordant alignments. Additional TopHat parameters selected for the final analysis included read-edit-distance (27) and read-realign-edit-distance (20) , with all other parameters at the default values. The paired-read numbers ranged from 30 to 60 million pairs and were mapped with an overall mapping rate of 86% to 88%, with 76% to 79% concordant pair alignments (Supplemental Table 1 ). Cufflinks, version 2.1.1, was used to assemble the aligned reads into transcripts based on Ensembl Ovis Aries release-74. The cufflinks workflow, programs, and descriptions of the functions for individual programs are available through a GitHub site (http://cole-trapnell-lab. github.io/cufflinks/manual/). Transcripts were assembled using only release 74 annotated transcripts (parameter: 2G) without novel transcript discovery (16) . To capture the highly abundant transcripts expected from specialized endocrine cells, the maximum number of reads allowed for a single locus (parameter: max-bundle-frags) was set to 25 million. CuffDiff was used to determine differential gene expression using the fragment bias correction and a minimum alignment count of 24.
For statistical analysis, library normalization used the geometric (default) method, and the cross-replicate dispersion estimation used the pooled (default) method. The significance cutoff after multiple testing correction (Q value) was 0.05. The sheep genome was the primary source for gene expression analysis, but additional pancreas-related annotations were obtained with the bovine genome. Normalized gene expression is presented as fragments per kilobase exon per million reads mapped (FPKM). The bioconductor package CummeRbund was used to visualize the results.
Gene ontology (GO) terms and canonical pathways for differentially expressed (DE) genes in IUGR islets were identified with KOBAS, version 2.0 (17) . Functional terms were significantly enriched if P , 0.05 after a Fisher's exact test with the Benjamini Hochberg correction. To summarize GO enrichment and reduce redundant terms, DE genes were further analyzed with online tools agriGO and ReviGO (18, 19) . The gene symbol identifications presented were approved by the Human Genome Organization gene nomenclature committee.
Validation of gene expression
Fold changes for gene expression from RNAseq analysis were correlated with 19 genes from previous and new quantitative reverse transcription polymerase chain reaction (RT-PCR) results from an expanded cohort of IUGR (n = 7) and control (n = 6) islets (20) . R was calculated in Prism, version 7.0 (GraphPad Software Inc., La Jolla, CA). Nucleic acid extraction and reverse transcription to synthesize the cDNA library was performed as described previously (13, 20) . In brief, RNA was isolated with RNAeasy (QIAGEN), and the purity and concentration were determined by absorbance measurements at 260 and 280 nm wavelengths with a NanoDrop ND-1000 spectrophotometer (NanoDrop, Wilmington, DE). The RNA quality was assessed with an Experion analyzer (Bio-Rad, Hercules, CA). RNA (1 mg/reaction) was reverse transcribed, in triplicate, into cDNA with Superscript III reverse transcription (Invitrogen, Carlsbad, CA). Synthetic oligonucleotide primer sequences and gene accession numbers are provided in Supplemental Table 2 . Optimal annealing temperatures for primers were determined with PCR. The primer specificity at this temperature was confirmed by nucleotide sequencing the cloned PCR product (pCR 2.1-TOPO vector, catalog no. K451020; Thermo Fisher Scientific Life Sciences, Waltham, MA). Primer efficiencies were measured with serial cDNA dilutions. All primers had efficiency $85%, and the threshold cycles (CT) were linear over six orders of magnitude. The relative expression of messenger RNA (mRNA) for each islet cDNA was determined using SYBR Green (QIAGEN) in a CFX Connect Real-Time PCR Detection System (Bio-Rad). After an initial 15 minutes, denaturation incubation at 96°C; all reactions went through 45 cycles at 96°C (30 seconds), annealing temperature (30 seconds), and 72°C (10 seconds) extension, and read. To ensure product homogeneity, a melt-curve analysis was performed. CT values were normalized using the reference gene, ribosomal protein s15. The fold change was calculated using the 2 2DDCT method (21).
Immunohistochemistry
For immunofluorescent staining, the IUGR and control fetuses (n = 5/treatment) were selected at random from an independent cohort previously reported (6) . Pancreas sections were stained for endocrine hormones and macrophages (Table 1 ) (22) . Immunostaining with no primary antibodies served as the negative control, and the spleen was used as a positive control. Fluorescent images were digitally captured using a Hamamatsu ORCA flash4.0LT (Hamamatsu Photonics, Hamamatsu, Japan). The islet area and macrophage density were measured in .11 random fields of view. Data are expressed as the number of Iba-1 positive cells per islet area (mm 2 ) for 61 6 15 IUGR islets and 53 6 7 control islets per animal. An unpaired, twotailed t test was performed to determine the difference in mean using Prism, version 7.0 (GraphPad).
Results
RNAseq identified differential transcriptome expression in IUGR islets
The IUGR fetuses had lower plasma glucose concentrations (0.6 6 0.1 vs 1.1 6 0.1 mM; P , 0.01) and blood oxygen content (1.2 6 0.2 vs 3.4 6 0.1 mM; P , 0.001) compared with the control fetuses. The IUGR fetuses weighed less than the control fetuses (1.3 6 0.03 vs 3.5 6 0.2 kg; P , 0.001) near term (Supplemental Table 1 ). RNAseq results from the control and IUGR islets identified 13,293 genes when annotated to sheep. The data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus and are accessible through Gene Expression Omnibus series accession no. GSE90022. The similarity of gene expression in the samples was visualized using a multidimensional scaling plot, which revealed greater variation within control islets than IUGR islets (Supplemental Fig. 1 ). Nearly 75% of genes detected in fetal sheep islets are found in RNAseq data of adult human islets, including all the mature pancreatic hormones and genes associated with endocrine cells, including PDX1, NKX6-1, NKX2-2, MAFA, MAFB, PAX6, and PAX4 (unpublished data). PAX4 was the only one of these genes Fig. 1(a) ]. Of the 1065 genes, 679 were downregulated and 386 were upregulated in the IUGR islets compared with the controls. In an analysis using the sheep genome, 114 DE genes were identified as novel transcripts; however, 34 of these genes were subsequently defined with bovine orthologs and included in the functional analysis. One noncoding transcript, microRNA 5047 (ENSOARG00000024483), was markedly increased in IUGR islets (.2000-fold).
Genes coding for proteins were filtered based on expression to define the 10 most downregulated genes (minimum 50 FPKM for the control) and 10 most upregulated genes [minimum 50 FPKM for IUGR; Fig. 1(b) ]. Downregulated genes were grouped into two categories: immune molecules and cellular structure. The immunerelated molecules were CXCL6, IL6, LIF, ISG17, and RSAD2. Genes that have been reported to regulate cell growth include REG3A and CRABP2 and KRT7 and claudins (CLDN4, CLDN6) represent cell structure and size. The upregulated genes predominantly functioned in stress responses (HIF3A, HSPA6, SLC16A12) and insulin secretion and mitochondrial regulation (GPR119, OGT, GHRL, GABPB2).
The fold changes of 19 genes were measured with RT-PCR in an expanded cohort of IUGR and control islets and compared with the RNAseq results (Supplemental Table 2 ). The fold changes for these two methods correlated positively (R = 0.90; P , 0.0001; Fig. 2 ) and validated the RNAseq findings.
Functional analysis identified immune, metabolic, growth, and structural processes
In IUGR islets, enriched GO terms were identified for all DE genes. Highly relevant biological processes were broad, yet contained subprocesses that explain specific IUGR islet responses ( Table 2 ). For example, some genes were associated with mitochondrial transport and cellular respiration and with cell cycle and mitotic nuclear division.
The enriched canonical pathways (P , 0.05) for DE genes were cell connectivity, insulin secretion, metabolic pathways, and tumor necrosis factor-a signaling (Table 3) . None of the genes within a pathway were found in other relevant pathways, except for three genes involved in cell structure and tissue remodeling: collagen (COL1A1 and COL5A2) and plasminogen activator (PLAT). Also, cyclic adenosine monophosphate-dependent transcription factor 4 (ATF4; decreased 2.1-fold) was found in insulin secretion and tumor necrosis factor-a signaling pathways (Supplemental Table 3 ). 
Downregulated genes encode metabolic processes and upregulated genes encode stress responses
Although numerous cellular components and molecular functions were represented in the analysis of all DE genes due to the extensive number of genes, directional comparisons identified specific categorical terms (the most relevant terms; Table 4 ). The biological processes from upregulated genes included response to stress, death, and apoptotic processes. The biological processes specific to downregulated genes included mitochondrial metabolism, M phase, and proteolysis. The cellular components specific to downregulated genes included cytoplasmic vesicles, tight junctions, and filaments, indicating decreased vesicle formation, cell connectivity, and cell size. In contrast, the synaptic vesicle was an enriched cellular component that was specific to upregulated genes.
Functional information and gene expression that define established derangements in IUGR islets
DE genes that regulate cell proliferation were consistent with slower rates of b-cell replication in islets from IUGR fetuses (Fig. 3) (6, 10) . Proproliferative genes such as RPS6KA1, CDKN1A, and CCNB2 were lower in the IUGR islets. The regulatory elements and transcription factors [ Fig. 3(e) ] involved in adaptive stress response include NUPR1 and IER3 (lower expression in IUGR), and C-FOS and MAF expression were greater in IUGR islets. Furthermore, the growth factors that promote cell growth and survival (IGF2, IGF1R, and IGF2R) were upregulated in IUGR islets but IGF2BP1 was reduced 2.9-fold [ Fig. 3(c) ].
DE genes were also associated with insulin stimulussecretion coupling, consistent with known physiological impairments. GLUT2 and GLUT3 (SLC2A2 and SLC2A3) were greater in IUGR islets (2.2-fold and 2.3-fold, respectively), promoting glucose entry even during fetal hypoglycemia. Also, two enzymes that are regulators of glycolysis were greater in IUGR islets, PFKFB2 and OGT. Normal oxidative glucose metabolism reflects cellular redox state, and redox regulatory genes and mitochondrial uncoupler (UCP2) were lower in the IUGR islets (Table 5 ). Insulin release is also dependent on G-protein coupled receptor (GPCR) amplification, ion channels that 
Biological processes are GO terms that were significantly enriched using the online database agriGO; the general processes were highly significant, and the significant child terms were manually curated to show more descriptive processes. Substantially enriched canonical pathways using all differentially expressed genes in IUGR islets were determined using KOBAS and KEGG public databases. The frequency of genes both associated with a pathway and differentially expressed in islets is presented, along with the fractional representation (percentage) of the total available in the reference sheep background (OAs). Corrected P value determined using Fisher's exact test. Pathways were manually curated for proteins uniquely discovered; complete lists of gene identifications are listed in Supplemental Table 3 .
Abbreviations: ECM, extracellular matrix; TNF-a, tumor necrosis factor-a. (Table 6 ).
Changes in expression of immune genes are not due to macrophage density in islets
Our transcriptome analysis showed widespread downregulation of immune signaling in IUGR islets. Therefore, we determined the macrophage density in islets by immunostaining fetal pancreas sections from control and IUGR islets with Iba-1, a macrophage/microglia marker (Fig. 4) . The density of Iba-1-positive cells was not different between the control and IUGR islets [ Fig. 4(c) ].
Discussion
Our comprehensive analysis of the islet transcriptome in near-term IUGR fetuses identifies alterations in mRNA expression that define underlying causes of b-cell dysfunction. From clinical observations, epidemiological studies, and previous research in animal models of IUGR, we expected to identify genes that alter cell growth and proliferation, cellular metabolism, and insulin secretory pathways in IUGR islets or specifically in b-cells. In the present study, functional analysis of differentially expressed genes in the islets from IUGR fetuses confirmed these expectations and expanded our knowledge on regulatory genes involved in glucose metabolism, redox mechanisms, cell cycle regulation, growth factor activity, and exocytosis. Expression analysis also identified functional processes not previously associated with IUGR islet dysfunction ( Table 7) . We are able to predict increased wnt signaling and adaptive hypoxia response and decreased immune function and proteasome activity in IUGR islets. Immune-related genes were overrepresented in the list of DE genes. However, these immune-related genes did not influence the number of resident macrophages in the fetal islets. This suggests the immunological DE genes identified might have nonclassic effects on other cell types, such as endocrine cells, and regulate cell proliferation and function (23) (24) (25) . Collectively, the genes and their known actions not only explain current areas of dysfunction but also provide the foundation for regulatory processes in islets that are permanently affected by IUGR.
Regulation of b-cell mass
Functional analysis of DE genes revealed the reductions in cell growth and the potential for apoptosis and antiapoptotic survival mechanisms as predominant processes in IUGR islets. In the fetus, b-cell mass is influenced by the rates of proliferation, apoptosis, and neogenesis (differentiation). Previous findings from this IUGR model showed that the reduced b-cell mass is due to slower mitotic rates but the number of cells in the cell cycle interphase was similar, indicating a lengthened cell cycle for b-cells, rather than quiescence (6, 8, 10) . Further analysis indicated that a slower replication rate was the primary mechanism for reduced b-cell mass in IUGR fetuses, because no differences were found in b-cell size, apoptosis, or neogenesis (6, 10) . The transcriptome data support these findings and begin to explain the molecular mechanisms involved in reduced b-cell mass after IUGR. Mitotic nuclear division, cell cycle arrest, and cellular biogenesis are functional categories enriched in IUGR islets and are consistent with slower proliferation rates in IUGR b-cells. Cell cycle arrest is associated with decreased expression of p21 (CDKN1A), cyclin b2 (CCNB2), cell division cycle 20 (CDC20), and increased expression of cyclin-dependent kinases (CDK19, CDKL5), the antiproliferative BTG2, and GABPB2. BTG2, CDKN1A, and GABPB2 are known regulators between the G 1 and S phase through proliferating cell nuclear antigen and proliferating cell nuclear antigen-independent pathways (26, 27) . Moreover, cell cycle progression is driven by degradation of cyclin proteins, and several proteasome subunits are lower in IUGR islets, indicating reduced rates of proteolysis and a lengthened cell cycle (28) . Two cyclindependent kinases are greater in IUGR islets (CDK19, CDKL5) and represent important candidates because their proposed actions are independent of cell cycle regulation. CDK19 is one of the only cyclin-dependent kinases that inhibits the mediator complex and represses target genes, including immune and differentiation factors. CDKL5, similar to CDK5, might regulate insulin exocytosis (29, 30) . The transcriptome profile in IUGR islets at this point in late gestation identified targets in cell cycle progression, proteolytic dysregulation, and noncanonical cyclindependent kinase signaling.
Although apoptosis was not shown previously, "apoptosis induction by hormone" was significantly enriched from lower expression of somatostatin and greater expression of SSTR3, which is the only somatostatin receptor that induces apoptosis by activation of p53 and the proapoptotic protein Bax (10, 31) . Given that the IUGR islets had lower Bax expression and no differences in proapoptotic Bcl2 family members, apoptosis is not expected to play a major role in reducing the b-cell mass. The microRNA 5047, which is abundant exclusively in IUGR islets, is predicted to lower rates of apoptosis and have additional actions in microRNA processing (32) . Generally, these data support original findings for no change in apoptotic rates but also indicate induction of protective mechanisms.
Three previously unidentified processes enriched in DE genes further explain the slower proliferation rates in IUGR b-cells. These are inhibition of wnt signaling, alterations in transforming growth factor (TGF)-b signaling, and decreased regenerative and growth factor expression. Nearly 80% of wnt signaling proteins whose mRNA were differentially expressed in IUGR islets are negative regulators of wnt signaling (CXXC4, LRP4, TLE1, PRICKLE2), and wnt signaling promotes b-cell proliferation (33) . The TGF-b activin subfamily, including inhibins [A, BA, and BE; Fig. 3(d) ], regulates b-cell proliferation and has lower expression in IUGR islets (33) . These subunits combine to form activins or inhibins that signal through receptors, such as ALK7 (increased; P , 0.07), to influence the b-cell mass (34) . Furthermore, TGF-b member TBRG4 (decreased; P , 0.01) is hypothesized to relate to G 1 cycle arrest, likely through RNA-binding kinase activity (35, 36) . The b-cell mass is also influenced by hormones and growth factors, and several candidates are altered in IUGR islets 
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Differentially expressed genes that produce proteins involved in cellular redox state were decreased in IUGR islets; fold change is log 2 transformed. Differentially expressed genes that produce proteins involved in membrane vesicle trafficking and exocytosis were increased in IUGR islets; fold change is log 2 transformed.
[ Fig. 3(c) ]. REG3A is reduced 98% in IUGR islets, and this finding was validated by RT-PCR. REG3A codes for a pancreas-specific protein involved in human and rodent b-cell proliferation, and studies have identified members of the regenerating protein family (Reg family) as a programming mechanism for impaired b-cell plasticity postnatally after fetal nutrient deprivation (37, 38) . These data also confirm previous evidence that insulin-like growth factor (IGF)2 and IGF binding protein (IGFBP2) mRNA were greater in IUGR islets (20) . IGF2BP1 mRNA was downregulated in IUGR islets, implicating posttranslational regulation, because IGF2BP1 is an RNAbinding protein that mediates internal ribosomal entry for IGF2 leader 3 transcripts but also recognizes c-myc, tau, b-actin, and H19 RNA (39) . Additional growth factors that were differentially expressed include nerve growth factor (NGF) and numerous cytokines (e.g., interleukin-1b; IL1B) or chemokines (e.g., CXCL12 and CXCR4). IL1B and NGF are produced by b-cells and neighboring fetal cells to influence b-cell maturation, function, protein synthesis, and apoptosis through paracrine/autocrine signaling (40, 41) . For example, suppression of NGF from b-cells in vitro led to apoptosis, suggesting NGF availability contributes to b-cell survival and islet maturation (42) .
Regulation of b-cell function Insulin secretion, metabolism, Ca 2+ signaling, and vesicle exocytosis were enriched processes in our analysis of the DE genes, consistent with the intrinsic islet defects shown previously in these IUGR islets (11) . Isolated islets from IUGR fetuses have impaired glucose-stimulated insulin secretion caused by lower insulin content in b-cells and diminished glucose oxidative rate in stimulatory glucose concentrations. However, fractional insulin secretion is greater in IUGR islets than in controls, indicating more efficient insulin release, which can be explained by enhanced metabolic coupling or distal secretory mechanisms (11) . The RNAseq data indicated greater glycolytic capacity and distal mechanisms affecting insulin secretion but also dysfunctional mitochondrial respiration. Insulin secretion is tightly coupled to glucose metabolism (43) . IUGR islets have increased expression of genes regulating glucose uptake and glycolytic potential. Despite the bidirectionality of 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase 2 as a glycolytic enzyme, an Lower expression of redox genes and UCP2 enhances stimulus-secretion coupling and might be regulated by glucose or catecholamine concentrations (45) (46) (47) (48) . Additionally, the transcription factors for mitochondrial genes (GABPB2 and PPARA) are greater in IUGR islets, which might enhance oxidative phosphorylation; however, these genes would also promote fatty acid oxidation and spare glucose during nutrient deprivation (49) . If glucose was no longer a limiting substrate, increased glucose uptake and glycolysis with less leakage in the mitochondria would explain postnatal hyperinsulin secretion; however, the loss of protective redox enzymes in this situation would make the islets more susceptible to oxidative stress (2, 4, 50) .
The IUGR islet transcriptome also displays adaptations in membrane potential and increased vesicle exocytosis in IUGR islets that support dysregulation of distal insulin secretory mechanisms. The processes for signaling, granule docking, and efficient granule exocytosis all represent distal mechanisms that are postulated to cause the increased fractional insulin secretion in IUGR islets. These processes are also regulated by calcium flux during stimulation, which is influenced by differences in hyperpolarizing channels expressed in b-cells. The GO term "synaptic vesicles" is indicated only for upregulated genes. Although we recognize that vesicle genes might stem from a greater fractional nerve area, many of these synaptic vesicle proteins, SYT15, STX16, SYT7, and PCLO, also function in calcium binding and cytokinesis, indicating a potential role in insulin vesicle docking and exocytosis after calcium influx in b-cells (51) . SYT7 is the most abundant synaptotagmin in b-cells, and SYT7 knockout mice have impaired glucose-stimulated insulin secretion and the loss of calcium-induced glucagon secretion from a-cells (52) . Synaptic proteins represent important targets for understanding compensatory insulin secretion after IUGR (47) .
Previously undefined adaptations in IUGR islets
Our analysis of the IUGR islet transcriptome identified several processes that have been shown to regulate islet function but have not been previously defined in IUGR islets (Table 7) . For example, wnt signaling and proteasome were already discussed in the context of b-cell mass and represent mechanisms for further study. We have shown that the genes related to immune processes are overwhelmingly downregulated and the genes involved in adaptive responses to hypoxia are upregulated in IUGR islets.
More than 20 cytokines are decreased in IUGR islets, including the cytokine-cytokine receptor axis in which both ligand and receptor are differentially expressed. We have demonstrated that lower cytokine expression is independent from changes in macrophage density within IUGR islets using immunohistochemistry, which is important because resident islet macrophages have an established role in maturation of the b-cell mass (53, 54) . The alternative is that changes in cytokine expression are attributable to endocrine cells and directly influence b-cell function. Several differentially expressed cytokine receptors are located on the pancreatic b-cell membrane, including CXCR4, CXCR3, and CXCL12 (24, 25) . The most downregulated genes in IUGR islets include cytokines IL8, IL6, and LIF. IL6 and LIF elicit similar effects on nonimmune cells through binding of ubiquitously expressed gp130 (IL6ST). In rodents, LIF induced b-cell maturation from exocrine cells (23) . In IUGR fetuses from pre-eclamptic mothers or hypoxic rodents, an increase in immune activity seems to be present (55, 56) . These reports characterize the much later insult of IUGR in gestation than in our model of placental insufficient sheep and give credence to the complexity of IUGR onset and the fetal response to nutrient and oxygen restriction. The islets we have sequenced were also from near-term fetuses; however, the placental insufficiency occurred early and independently of maternal hypertension, such that the insult progressively worsens during the final third of gestation (8, 11, 57) . It is reasonable to speculate that the prolonged development of nutrient and oxygen sparing has reduced allocations to the immune systems. This hypothesis is supported by findings in IUGR Major genes involved in these processes are listed; the predicted activity in IUGR was determined by manual review of gene expression and its effect on the process.
neonates, which are more susceptible to infections owing to reduced white blood cell and neutrophil levels (58) . Although the transcriptome analysis did not indicate the classic acute hypoxic response, evidence of adaptive responses to hypoxia has been shown. These include changes in genes associated with vascularity and endothelial function and an increase in hypoxia inducible factor HIF3A (Table 7) . IUGR fetuses are hypoxemic, because the blood oxygen content and partial pressure of oxygen are lower; however, the extent of hypoxia for tissues remains unclear (59, 60) . In islets, the adaptation to hypoxia is primarily dependent on ample vasculature, which is reduced at 68% of gestation but not different at 90% of gestation (61) . In these data, the expression of vascular endothelial growth factor (VEGF) receptor (FLT1) was greater in IUGR islets and VEGFA and VEGFB were unchanged, consistent with histologic data (61) . Some of the genes with the largest fold changes in IUGR islets are associated with endothelial cell function. Heme oxygenase 1 (HMOX1) is expressed abundantly in control islets and reduced in IUGR islets, which we confirmed with RT-PCR. HMOX1 expression has anti-inflammatory and antioxidative effects and overexpression of HMOX1 is cytoprotective in b-cells (62) . Also, NOS2 is decreased, and GC is increased in IUGR islets. GC is an established response to prolonged stress on endothelial cells and promotes growth (63) . Together, greater VEGFR and GC expression with lower HMOX1 and NOS2 expression provide a framework for compensatory vascular response of IUGR islets. On a cellular level, hypoxia is sensed through hypoxia inducible factor (HIF) proteins. HIF1a is post-translationally modified in response to hypoxia and its expression is not different between treatments. However, HIF3a mRNA was increased. Unlike HIF1a, HIF3a antagonizes HIF1a by negatively regulating the transcription of genes associated with hypoxia responses (64, 65) . Thus, HIF3a is an interesting candidate for adaptation to the persistent hypoxia seen in the IUGR fetus.
Conclusion
The IUGR islet transcriptome profile identified several mechanisms that reduce b-cell mass and impair b-cell function. In addition to refining our understanding for processes previously described, these findings elucidate previously unrecognized mechanisms for b-cell dysfunction that regulate immune and adaptive hypoxic stress responses. These transcriptional changes define adaptive responses of b-cells during IUGR and could provide the foundation for understanding the programming mechanisms resulting from prolonged nutrient deprivation that lead to metabolic complications in later life.
